March 9 (Reuters) - Vertex Pharmaceuticals said on Monday that its experimental kidney disease drug met the main goal of a late-stage trial. Shares of the company were up about 10% in extended trading ...

The drug maker says its treatment of a rare kidney disease met its main goal in a late-stage trial.

Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.

Vertex Pharmaceuticals Inc. shares rose after the biotech company said its drug to treat a kidney disorder met its goal in a ...

Company shares surged in after-market trading on results for a drug Vertex acquired in a multibillion-dollar deal and sees as ...

Add Yahoo as a preferred source to see more of our stories on Google. The drug finerenone, made by pharma giant Bayer and marketed under the brand name Kerendia, was found to be effective in treating ...

First new drug in 30 years to slow kidney disease in type 1 diabetes ...

Those with a higher risk of kidney disease, such as diabetics or people with high blood pressure, should be particularly ...

aProximate TM PTCs maintain high expression of key transporters involved in drug handling, including megalin and cubilin, making them ideal for studying drug transporters and drug interactions with ...

NEW YORK (Reuters Health) - People with failing kidneys may frequently use "natural" or homeopathic products and over-the-counter medications that could worsen their kidney function, a new study shows ...

Health warning as common painkiller linked to kidney damage - Drugs like ibuprofen can elevate blood pressure and damage blood vessels ...